Profiel
Trevor Langley is the founder of KWS BioTest Ltd., where he holds the title of Managing Director starting in 2004.
He is currently working as a Non-Executive Director at Fixed-Phage Ltd.
Actieve functies van Trevor Langley
| Bedrijven | Functie | Begin |
|---|---|---|
KWS BioTest Ltd.
 KWS BioTest Ltd. Pharmaceuticals: MajorHealth Technology KWS BioTest Ltd. provides preclinical pharmacology and drug development for human diseases. Its capabilities include clinical biomarkers, cell biology, bioanalytical services, in vivo pharmacology, vaccine development. The company was founded by Williams A. Neil and Trevor Langley in 2004 and is headquartered in Bristol, the United Kingdom. | Oprichter | 01-01-2004 |
Fixed-Phage Ltd.
 Fixed-Phage Ltd. Medical/Nursing ServicesHealth Services Fixed-Phage Ltd. provides research for treatment and prevention of infection and bacterial contamination. The firm is engaged in developing and commercializing bacteriophage immobilization and stabilization technology. The company was founded by Mike Mattey and is headquartered in Glasgow, the United Kingdom. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
KWS BioTest Ltd.
KWS BioTest Ltd. Pharmaceuticals: MajorHealth Technology KWS BioTest Ltd. provides preclinical pharmacology and drug development for human diseases. Its capabilities include clinical biomarkers, cell biology, bioanalytical services, in vivo pharmacology, vaccine development. The company was founded by Williams A. Neil and Trevor Langley in 2004 and is headquartered in Bristol, the United Kingdom. | Health Technology |
Fixed-Phage Ltd.
Fixed-Phage Ltd. Medical/Nursing ServicesHealth Services Fixed-Phage Ltd. provides research for treatment and prevention of infection and bacterial contamination. The firm is engaged in developing and commercializing bacteriophage immobilization and stabilization technology. The company was founded by Mike Mattey and is headquartered in Glasgow, the United Kingdom. | Health Services |
